BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19032953)

  • 1. PDGF receptors are activated in human epiretinal membranes.
    Cui J; Lei H; Samad A; Basavanthappa S; Maberley D; Matsubara J; Kazlauskas A
    Exp Eye Res; 2009 Mar; 88(3):438-44. PubMed ID: 19032953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
    Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of platelet-derived growth factor on the formation of proliferative vitreoretinopathy].
    Liang Y; Li X; Fan J; Zhao M; Jiang Y
    Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):144-7. PubMed ID: 11955317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy.
    Lei H; Hovland P; Velez G; Haran A; Gilbertson D; Hirose T; Kazlauskas A
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2335-42. PubMed ID: 17460299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth factors outside the PDGF family drive experimental PVR.
    Lei H; Velez G; Hovland P; Hirose T; Gilbertson D; Kazlauskas A
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3394-403. PubMed ID: 19324843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmin is the major protease responsible for processing PDGF-C in the vitreous of patients with proliferative vitreoretinopathy.
    Lei H; Velez G; Hovland P; Hirose T; Kazlauskas A
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):42-8. PubMed ID: 18172073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electron-immunostaining characteristics of platelet-derived growth factor, transforming growth factor beta1 and their receptors in epiretinal membranes].
    Wang F; Xu X; Zhang X; Yan Y
    Zhonghua Yan Ke Za Zhi; 2000 Sep; 36(5):369-71, 24. PubMed ID: 11853632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-independent activation of platelet-derived growth factor receptor β promotes vitreous-induced contraction of retinal pigment epithelial cells.
    Duan Y; Wu W; Cui J; Matsubara JA; Kazlauskas A; Ma G; Li X; Lei H
    BMC Ophthalmol; 2023 Aug; 23(1):344. PubMed ID: 37537538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDGFRβ plays an essential role in patient vitreous-stimulated contraction of retinal pigment epithelial cells from epiretinal membranes.
    Yang Y; Huang X; Ma G; Cui J; Matsubara JA; Kazlauskas A; Zhao J; Wang J; Lei H
    Exp Eye Res; 2020 Aug; 197():108116. PubMed ID: 32561481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses.
    Pennock S; Kazlauskas A
    Mol Cell Biol; 2012 May; 32(10):1955-66. PubMed ID: 22431518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy.
    Lei H; Rheaume MA; Kazlauskas A
    Exp Eye Res; 2010 Mar; 90(3):376-81. PubMed ID: 19931527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
    Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
    Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy.
    Cui JZ; Chiu A; Maberley D; Ma P; Samad A; Matsubara JA
    Eye (Lond); 2007 Feb; 21(2):200-8. PubMed ID: 16531976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived growth factor and basic fibroblast growth factor immunolocalized in proliferative retinal diseases.
    Liang X; Li C; Li Y; Huang J; Tang S; Gao R; Li S
    Chin Med J (Engl); 2000 Feb; 113(2):144-7. PubMed ID: 11775539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
    Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
    Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
    J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoforms of platelet-derived growth factor and its receptors in epiretinal membranes: immunolocalization to retinal pigmented epithelial cells.
    Vinores SA; Henderer JD; Mahlow J; Chiu C; Derevjanik NL; Larochelle W; Csaky C; Campochiaro PA
    Exp Eye Res; 1995 Jun; 60(6):607-19. PubMed ID: 7641844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes.
    Telander DG; Yu AK; Forward KI; Morales SA; Morse LS; Park SS; Gordon LK
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3112-7. PubMed ID: 27294805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDGF-D, a new protease-activated growth factor.
    LaRochelle WJ; Jeffers M; McDonald WF; Chillakuru RA; Giese NA; Lokker NA; Sullivan C; Boldog FL; Yang M; Vernet C; Burgess CE; Fernandes E; Deegler LL; Rittman B; Shimkets J; Shimkets RA; Rothberg JM; Lichenstein HS
    Nat Cell Biol; 2001 May; 3(5):517-21. PubMed ID: 11331882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
    Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
    Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.